Updated Oct 9, 2026 · 04:30 UTC
AMGNAmgen
Health Care · United States · XNAS · biological products, (no diagnostic substances)
$407.12−1.37%last session · market closed
Market cap
$220.10b
real-world
Tokenized
$6k
<0.001% of the asset
Avg token price
$411.89
+1.17% vs real
Spot volume, 24h
$301k
4 venues
Derivatives, 24h
—
Perp open interest
—
In DeFi
—
AMGN · Price
Jan 10, 2026low $323.86 · high $450.71 · now $406.12Oct 7, 2026
Token Real
Earnings
Nasdaq’s earnings calendar
Next earnings
Nov 3
estimated date · Sep 2026 quarter · EPS forecast $5.69 (9 analysts)
Last earnings, Aug 4
$6.29 EPS
+12.3% vs $5.60 forecast · Jun 2026 quarter
Real market
Amgen Inc
Last close
$413.08
Oct 7
Traded on Oct 7
$922.4m
Price now
$407.12
market closed
Where it trades
24h volume by venue, as the exchanges report it · open interest and funding on the perpetuals
Spot · $301k · 4 venues
MEXC1 pair$156k
Blynex1 pair$145k
Ondo Stocks1 pair$21Derivatives · — · 0 venues
None yet
Onchain versions
2 tokens from 2 issuers
AMGNonOndo Assets$411.76$6k
wAMGNxBacked Assets——By chain
Where the tokens circulate, issuers’ unsold stock taken off
Ethereum70%$4k
Solana30%$2kIn DeFi
Pools and lending markets that hold these tokens
None found
Business 12 months to Jun 2026 · SEC EDGAR
Results
Revenue
$38.09b
+9% YoY
Operating income
$11.43b
30% margin · +39% YoY
Net income
$8.74b
23% margin · +32% YoY
EPS, diluted
$16.07
+31% YoY
Cash and balance sheet
Free cash flow
$10.18b
27% of revenue
Net debt
$43.31b
$13.99b cash and securities, $57.30b debt
Diluted shares
544m
+1% YoY
Valuation at today’s market cap
P/E
25×
EV / sales
6.9×
enterprise value $263.41b
EV / operating income
23.1×
Free cash flow yield
4.6%
Quarterly
RevenueNet income